ReviewPharmacoEconomics2018

Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Keith Cooper et al.PubMed ↗Publisher ↗

No numbers read from the abstract.